Clinical Trial Update: Autologous Transplantation of Induced Pluripotent Stem Cell-Derived Retinal Pigment Epithelium for Geographic Atrophy Associated With Age-Related Macular Degeneration [Phase 1, Phase 2]

View source ↗

Summary

An early-stage clinical trial is evaluating autologous induced pluripotent stem cell-derived retinal pigment epithelium transplantation for geographic atrophy a…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Age-related Macular Degeneration
• Geographic Atrophy

Drugs mentioned

• Autologous iPSC-derived retinal pigment epithelium transplantation (induced pluripotent stem cell-derived retinal pigment epithelium (iPSC-RPE) autologous transplant)

Snippet

Sponsor: National Eye Institute (NEI) | Conditions: Dry Age-Related Macular Degeneration, Geographic Atrophy | Phase 1, Phase 2 | Status: RECRUITING